• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型海洋吡喃异吲哚啉化合物增强单链尿激酶型纤溶酶原激活剂介导的纤维蛋白溶解。

A Novel Marine Pyran-Isoindolone Compound Enhances Fibrin Lysis Mediated by Single-Chain Urokinase-Type Plasminogen Activator.

机构信息

Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.

Shanghai Engineering Research Center of Aquatic-Product Processing and Preservation, Shanghai 201306, China.

出版信息

Mar Drugs. 2022 Jul 30;20(8):495. doi: 10.3390/md20080495.

DOI:10.3390/md20080495
PMID:36005498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9410493/
Abstract

Fungi fibrinolytic compound 1 (FGFC1) is a rare pyran-isoindolone derivative with fibrinolytic activity. The aim of this study was to further determine the effect of FGFC1 on fibrin clots lysis in vitro. We constructed a fibrinolytic system containing single-chain urokinase-type plasminogen activator (scu-PA) and plasminogen to measure the fibrinolytic activity of FGFC1 using the chromogenic substrate method. After FITC-fibrin was incubated with increasing concentrations of FGFC1, the changes in the fluorescence intensity and D-dimer in the lysate were measured using a fluorescence microplate reader. The fibrin clot structure induced by FGFC1 was observed and analyzed using a scanning electron microscope and laser confocal microscope. We found that the chromogenic reaction rate of the mixture system increased from (15.9 ± 1.51) × 10−3 min−1 in the control group to (29.7 ± 1.25) × 10−3 min−1 for 12.8 μM FGFC1(p < 0.01). FGFC1 also significantly increased the fluorescence intensity and d-dimer concentration in FITC fibrin lysate. Image analysis showed that FGFC1 significantly reduced the fiber density and increased the fiber diameter and the distance between protofibrils. These results show that FGFC1 can effectively promote fibrin lysis in vitro and may represent a novel candidate agent for thrombolytic therapy.

摘要

真菌纤维蛋白溶解化合物 1(FGFC1)是一种罕见的吡喃-异吲哚啉衍生物,具有纤维蛋白溶解活性。本研究旨在进一步确定 FGFC1 对体外纤维蛋白凝块溶解的影响。我们构建了一个含有单链尿激酶型纤溶酶原激活剂(scu-PA)和纤溶酶的纤溶系统,使用比色底物法测量 FGFC1 的纤溶活性。用不同浓度的 FGFC1 孵育 FITC-纤维蛋白后,用荧光微孔板读数仪测量裂解液中荧光强度和 D-二聚体的变化。用扫描电子显微镜和激光共聚焦显微镜观察和分析 FGFC1 诱导的纤维蛋白凝块结构。我们发现,在对照​​组中,混合物系统的比色反应速率从(15.9 ± 1.51)×10−3 min−1增加到 12.8 μM FGFC1 的(29.7 ± 1.25)×10−3 min−1(p < 0.01)。FGFC1 还显著增加了 FITC 纤维蛋白裂解液的荧光强度和 d-二聚体浓度。图像分析表明,FGFC1 显著降低了纤维密度,增加了纤维直径和原纤维之间的距离。这些结果表明,FGFC1 可有效促进体外纤维蛋白溶解,可能代表溶栓治疗的一种新型候选药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/d12606f6daa2/marinedrugs-20-00495-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/ad92b0096758/marinedrugs-20-00495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/f28d9852a00d/marinedrugs-20-00495-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/362ac2eecf7d/marinedrugs-20-00495-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/96f0f342cd49/marinedrugs-20-00495-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/f6a6ccf15891/marinedrugs-20-00495-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/ef2df4dc342b/marinedrugs-20-00495-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/13225bc69f11/marinedrugs-20-00495-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/d12606f6daa2/marinedrugs-20-00495-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/ad92b0096758/marinedrugs-20-00495-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/f28d9852a00d/marinedrugs-20-00495-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/362ac2eecf7d/marinedrugs-20-00495-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/96f0f342cd49/marinedrugs-20-00495-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/f6a6ccf15891/marinedrugs-20-00495-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/ef2df4dc342b/marinedrugs-20-00495-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/13225bc69f11/marinedrugs-20-00495-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74e/9410493/d12606f6daa2/marinedrugs-20-00495-g008.jpg

相似文献

1
A Novel Marine Pyran-Isoindolone Compound Enhances Fibrin Lysis Mediated by Single-Chain Urokinase-Type Plasminogen Activator.一种新型海洋吡喃异吲哚啉化合物增强单链尿激酶型纤溶酶原激活剂介导的纤维蛋白溶解。
Mar Drugs. 2022 Jul 30;20(8):495. doi: 10.3390/md20080495.
2
Fungi Fibrinolytic Compound 1 Plays a Core Role in Modulating Fibrinolysis, Altering Plasma Clot Structure, and Promoting Susceptibility to Lysis.真菌纤溶化合物1在调节纤维蛋白溶解、改变血浆凝块结构以及促进溶解敏感性方面发挥核心作用。
Pharmaceutics. 2023 Sep 14;15(9):2320. doi: 10.3390/pharmaceutics15092320.
3
Effects of a novel marine natural product: pyrano indolone alkaloid fibrinolytic compound on thrombolysis and hemorrhagic activities in vitro and in vivo.新型海洋天然产物:吡喃并吲哚啉生物碱纤维蛋白溶解化合物对体外和体内溶栓和出血活性的影响。
Arch Pharm Res. 2015 Aug;38(8):1530-40. doi: 10.1007/s12272-014-0518-y. Epub 2014 Dec 5.
4
In Vitro Study of the Fibrinolytic Activity via Single Chain Urokinase-Type Plasminogen Activator and Molecular Docking of FGFC1.体外研究单链尿激酶型纤溶酶原激活剂的纤溶活性及 FGFC1 的分子对接
Molecules. 2021 Mar 24;26(7):1816. doi: 10.3390/molecules26071816.
5
Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic Agents.海洋吡喃-异吲哚啉酮衍生物的合成及生物活性作为潜在的抗血栓药物。
Mar Drugs. 2021 Apr 15;19(4):218. doi: 10.3390/md19040218.
6
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(scu-PA)和尿激酶在体外血浆环境中对血凝块溶解不存在协同作用。
Thromb Haemost. 1986 Aug 20;56(1):35-9.
7
Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.一种由纤维蛋白片段D - 二聚体特异性人源化单克隆抗体和截短的单链尿激酶组成的重组嵌合纤溶酶原激活剂的溶栓和药代动力学特性
Thromb Haemost. 1992 Aug 3;68(2):170-9.
8
Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.尿激酶原:其在血浆中的稳定性及选择性纤溶作用机制的研究
Blood. 1986 May;67(5):1215-23.
9
Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator.一种针对人纤维蛋白和尿激酶型纤溶酶原激活剂的双特异性单克隆抗体在体外和体内增强血凝块溶解作用。
Thromb Haemost. 1991 Dec 2;66(6):684-93.
10
Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.一种由纤维蛋白片段-D-二聚体特异性人源化单克隆抗体和截短的单链尿激酶组成的重组嵌合纤溶酶原激活剂的特性分析
Eur J Biochem. 1992 Apr 1;205(1):139-46. doi: 10.1111/j.1432-1033.1992.tb16761.x.

引用本文的文献

1
Exploring the fibrinolytic potential of marine Actinoalloteichus caeruleus isolated from Bay of Bengal coast.探索从孟加拉湾海岸分离出的海洋蓝色链霉菌的纤溶潜力。
BMC Microbiol. 2025 Mar 3;25(1):113. doi: 10.1186/s12866-025-03815-w.
2
Marine Fungi Bioactives with Anti-Inflammatory, Antithrombotic and Antioxidant Health-Promoting Properties Against Inflammation-Related Chronic Diseases.海洋真菌生物活性物质具有抗炎、抗血栓和抗氧化特性,可促进与炎症相关的慢性疾病的健康。
Mar Drugs. 2024 Nov 18;22(11):520. doi: 10.3390/md22110520.
3
Novel Deep Sea Isoindole Alkaloid FGFC1 Exhibits Its Fibrinolytic Effects by Inhibiting Thrombin-Activatable Fibrinolysis Inhibitor.

本文引用的文献

1
Progress in Isoindolone Alkaloid Derivatives from Marine Microorganism: Pharmacology, Preparation, and Mechanism.海洋微生物中异吲哚啉生物碱衍生物的研究进展:药理学、制备与作用机制。
Mar Drugs. 2022 Jun 20;20(6):405. doi: 10.3390/md20060405.
2
The Role of Fibrinolytic System in Health and Disease.纤维蛋白溶解系统在健康和疾病中的作用。
Int J Mol Sci. 2022 May 9;23(9):5262. doi: 10.3390/ijms23095262.
3
Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA.
新型深海异吲哚生物碱FGFC1通过抑制凝血酶激活的纤溶抑制因子发挥其纤溶作用。
Pharmaceuticals (Basel). 2024 Oct 20;17(10):1401. doi: 10.3390/ph17101401.
4
Recent advancement of novel marine fungi derived secondary metabolite fibrinolytic compound FGFC in biomedical applications: a review.新型海洋真菌来源的次级代谢产物纤溶化合物 FGFC 在生物医药应用中的研究进展:综述。
Front Cell Infect Microbiol. 2024 Sep 18;14:1422648. doi: 10.3389/fcimb.2024.1422648. eCollection 2024.
5
Study on Preclinical Safety and Toxic Mechanism of Human Umbilical Cord Mesenchymal Stem Cells in F344RG Rats.人脐带间充质干细胞在 F344RG 大鼠体内的临床前安全性及毒性机制研究。
Stem Cell Rev Rep. 2024 Nov;20(8):2236-2252. doi: 10.1007/s12015-024-10780-w. Epub 2024 Sep 7.
6
Fungi Fibrinolytic Compound 1 Plays a Core Role in Modulating Fibrinolysis, Altering Plasma Clot Structure, and Promoting Susceptibility to Lysis.真菌纤溶化合物1在调节纤维蛋白溶解、改变血浆凝块结构以及促进溶解敏感性方面发挥核心作用。
Pharmaceutics. 2023 Sep 14;15(9):2320. doi: 10.3390/pharmaceutics15092320.
通过与不同形式的 uPA 结合,DNA 适体对人尿激酶型纤溶酶原激活剂(uPA)酶活性和受体结合的抑制作用及其作为潜在治疗药物的研究
Int J Mol Sci. 2022 Apr 28;23(9):4890. doi: 10.3390/ijms23094890.
4
Heterogeneity of Genotype-Phenotype in Congenital Hypofibrinogenemia-A Review of Case Reports Associated with Bleeding and Thrombosis.先天性低纤维蛋白原血症中基因型-表型的异质性——与出血和血栓形成相关的病例报告综述
J Clin Med. 2022 Feb 18;11(4):1083. doi: 10.3390/jcm11041083.
5
Association of red cell distribution width and D-dimer levels with intracranial hemorrhage in patients with cerebral venous thrombosis.红细胞分布宽度和D-二聚体水平与脑静脉血栓形成患者颅内出血的相关性
Clin Neurol Neurosurg. 2022 Mar;214:107178. doi: 10.1016/j.clineuro.2022.107178. Epub 2022 Feb 17.
6
FGFC1 Selectively Inhibits Erlotinib-Resistant Non-Small Cell Lung Cancer Elevation of ROS Mediated by the EGFR/PI3K/Akt/mTOR Pathway.FGFC1选择性抑制由EGFR/PI3K/Akt/mTOR通路介导的活性氧升高的厄洛替尼耐药非小细胞肺癌。
Front Pharmacol. 2022 Jan 19;12:764699. doi: 10.3389/fphar.2021.764699. eCollection 2021.
7
FGFC1 Exhibits Anti-Cancer Activity via Inhibiting NF-κB Signaling Pathway in -Mutant NSCLC Cells.FGFC1 通过抑制 NF-κB 信号通路在 - 突变型 NSCLC 细胞中发挥抗癌活性。
Mar Drugs. 2022 Jan 17;20(1):76. doi: 10.3390/md20010076.
8
Marine Microbial Fibrinolytic Enzymes: An Overview of Source, Production, Biochemical Properties and Thrombolytic Activity.海洋微生物溶栓酶:来源、生产、生化特性和溶栓活性概述。
Mar Drugs. 2022 Jan 2;20(1):46. doi: 10.3390/md20010046.
9
Microscale structural changes of individual fibrin fibers during fibrinolysis.纤维蛋白纤维在纤溶过程中的微观结构变化。
Acta Biomater. 2022 Mar 15;141:114-122. doi: 10.1016/j.actbio.2022.01.006. Epub 2022 Jan 7.
10
Synthesis and Bioactivities of Marine Pyran-Isoindolone Derivatives as Potential Antithrombotic Agents.海洋吡喃-异吲哚啉酮衍生物的合成及生物活性作为潜在的抗血栓药物。
Mar Drugs. 2021 Apr 15;19(4):218. doi: 10.3390/md19040218.